Nuveen Asset Management, LLC I Teos Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 157,331 shares of ITOS stock, worth $1.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

157,331

Previous 358,171 56.07%

Holding current value

$1.29 Million

Previous $5.32 Million 69.78%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$10.09 - $17.97 $2.03 Million - $3.61 Million	-200,840 Reduced 56.07%	157,331 $1.61 Million
Q2 2024 Aug 09, 2024	SELL	$10.33 - $18.09 $133,566 - $233,903	-12,930 Reduced 3.48%	358,171 $5.32 Million
Q1 2024 May 13, 2024	BUY	$9.89 - $13.64 $1.76 Million - $2.42 Million	177,700 Added 91.88%	371,101 $5.06 Million
Q4 2023 Feb 14, 2024	BUY	$8.57 - $11.06 $1.14 Million - $1.48 Million	133,501 Added 222.87%	193,401 $2.12 Million
Q3 2023 Nov 14, 2023	SELL	$10.95 - $14.6 $173,130 - $230,840	-15,811 Reduced 20.88%	59,900 $655,000
Q2 2023 Aug 14, 2023	SELL	$12.93 - $18.05 $278,913 - $389,356	-21,571 Reduced 22.17%	75,711 $1 Million
Q1 2023 May 15, 2023	BUY	$13.02 - $22.62 $102,259 - $177,657	7,854 Added 8.78%	97,282 $1.32 Million
Q4 2022 Feb 14, 2023	SELL	$17.77 - $21.6 $189,712 - $230,601	-10,676 Reduced 10.66%	89,428 $1.75 Million
Q3 2022 Nov 14, 2022	SELL	$18.6 - $27.25 $2.4 Million - $3.52 Million	-129,173 Reduced 56.34%	100,104 $1.91 Million
Q2 2022 Aug 15, 2022	BUY	$16.57 - $35.1 $420,264 - $890,241	25,363 Added 12.44%	229,277 $4.72 Million
Q1 2022 May 16, 2022	BUY	$31.92 - $47.45 $464,946 - $691,156	14,566 Added 7.69%	203,914 $6.71 Million
Q4 2021 Feb 14, 2022	BUY	$26.23 - $47.86 $2.17 Million - $3.96 Million	82,799 Added 77.71%	189,348 $7.11 Million
Q3 2021 Nov 12, 2021	SELL	$23.91 - $29.58 $42,153 - $52,149	-1,763 Reduced 1.63%	106,549 $3.06 Million
Q2 2021 Aug 16, 2021	SELL	$17.9 - $36.1 $312,534 - $630,306	-17,460 Reduced 13.88%	108,312 $2.78 Million
Q1 2021 May 17, 2021	BUY	$30.86 - $44.2 $2.18 Million - $3.13 Million	70,784 Added 128.73%	125,772 $4.3 Million
Q4 2020 Feb 16, 2021	BUY	$21.59 - $33.95 $698,673 - $1.1 Million	32,361 Added 143.02%	54,988 $1.86 Million
Q3 2020 Nov 16, 2020	BUY	$17.57 - $32.92 $397,556 - $744,880	22,627 New	22,627 $558,000

Others Institutions Holding ITOS

# of Institutions

165

Shares Held

36.6M

Call Options Held

1.95M

Put Options Held

374K

View Full List

About iTeos Therapeutics, Inc.

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $293M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

More about ITOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC I Teos Therapeutics, Inc. Transaction History